Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

1 Cheap, Popular Robinhood Stock You’ll Want to Have on Your Radar

Published 2021-05-28, 08:00 a/m
1 Cheap, Popular Robinhood Stock You’ll Want to Have on Your Radar
BATS
-

While Canadian investors don’t have access to the Robinhood trading site, many use information coming from the site on a regular basis. Investors can simply look at the top stocks and decide what fits into their portfolio. The company has become synonymous with growth and, with that, a bit of risk. For millennials seeking growth over the long term, this can be an interesting strategy.

I don’t recommend this strategy as a whole purpose of investing, but having a few stocks with a bit of risk is alright. If most of your investments are in less-risky items, like large-cap stocks and exchange-traded funds (ETFs), your risk is diminished, leaving some room for a few cheap stocks, if you so choose.

On the whole I avoid cheap stocks because they’re too speculative. However, it doesn’t mean there aren’t some interesting options out there to dig into. So, let’s look at one stock on Robinhood I would keep on your radar.

A popular pot stock Cannabis stocks are known to be all over the Robinhood leader board. But one of the most popular is OrganiGram Holdings (TSX:OGI)(NASDAQ:OGI). The company is currently 29th on the top 100 list, with many investors sinking their teeth into it from the possibility of cannabis reform in the United States.

The new administration stated before the election that it would seek to decriminalize marijuana use on a federal level. The U.S. should have up to US$41.5 billion in annual cannabis sales as early as 2025, according to analysts. And this would considerably widen OrganiGram stock and its growth.

And yes, OrganiGram stock was hit by the wave of investment into cannabis, followed by the slouch. Shares climbed 160% in a year then fell by 57% to where it trades now. But there’s one huge difference that sets it apart from other cannabis stocks: share price.

Cannabis bought with confidence Instead of investing in this still risky industry and potentially losing a lot of money, you can buy OrganiGram stock for just $3.35 as of writing. Even if you buy a small stake of just $13.40, that’s not a lot to lose. On the flip side, should federal legalization go through, that’s about four stocks as of writing that could suddenly change to double digits.

And OrganiGram stock does have a reason to lead investor confidence. The company uses a three-tiered growing system to maximize the space it has for a cheaper cost. It thus provides a higher yield per square foot than competitors. It has also already invested in high-margin derivatives such as edibles and powders, which have seen a huge uptick in purchases.

Then there are its partnerships. British American Tobacco (LON:BATS) recently bought a 19.9% stake in OrganiGram stock in a $221 million investment. It sees the small Canadian cannabis producer as a potential for greatness. And when this major player taps your shoulder, you turn around pay attention.

Not without risk As I’ve stated, cheap stocks have risk. While OrganiGram stock may be popular on Robinhood, it doesn’t mean it’s safe. In fact, its latest earnings reports have been pretty poor. However, it has paid down debt and now has a balance of $232 million in cash and short-term investments. Meanwhile, management believes there will be improvement next quarter.

This comes from improved demand fulfillment from hiring more workers, a COVID-19 recovery, and an increase in soft chews and confectionary products. Furthermore, the yield per plant has already increased from optimizing the density of plants per room and decreasing vegetation time. This will drive down costs and increase inventory sold.

While this stock isn’t without risk, there is plenty to look forward to. And it’s definitely a Robinhood stock I would keep on my radar.

The post 1 Cheap, Popular Robinhood Stock You’ll Want to Have on Your Radar appeared first on The Motley Fool Canada.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends OrganiGram Holdings. The Motley Fool recommends OrganiGram Holdings.

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.